Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon
2017 ◽
Vol 534
(1-2)
◽
pp. 25-34
◽
Keyword(s):
1992 ◽
Vol 83
(1-3)
◽
pp. 65-72
◽
Keyword(s):
2018 ◽
Vol 8
(6)
◽
pp. 382-390
◽
Keyword(s):
Application of pressurized liquid extraction technology to pharmaceutical solid dosage form analysis
2002 ◽
Vol 968
(1-2)
◽
pp. 257-261
◽
Keyword(s):
Keyword(s):